Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-02-07

FDA Approved: ALLI — Original Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved ALLI (orlistat) from Haleon US Holdings LLC as an original NDA for weight loss in overweight or obese adults when used with a reduced-calorie diet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ALLI (orlistat)

Snippet

ORIG AP for ALLI (ORLISTAT)